Epidemiological disasters

Human Reproduction

Volumn 11, Issue 4, 1996, Pages 689-690

  Cohen, Jean ^a  

^a Clinique Marignan   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; FEMALE; HUMAN; REVIEW; THROMBOPHLEBITIS;

CONTRACEPTIVES, ORAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; THROMBOPHLEBITIS;

EID: 0030120079     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019226     Document Type: Review

References (9)

1. James, W.H. (1977) Br. Med. J.
2. Jamin, C. and De Mouzon, J. (1996) Selective prescribing of third-generation oral contraceptives (OCs). Contraception, (in press).
3. Jick, H., Jick, S S., Gurewich, V. et al. (1995) Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet, 346, 1589-1593.
4. Lewis, M.A., Spitzer, W.O., Heinemann, L.A.J. et al. (1996) Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Br. Med. J., 312, 88-90.
5. Pike, M.C., Henderson, B.E., Krailo, M.D. et al. (1983) Breast cancer in young women and use of oral contraceptives - possible modifying effect of formulation and age at use. Lancet, ii, 926-930.
6. Spitzer, W.O., Lewis, M.A., Heinemann, L.A.J et al. (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study Br. Med. J., 312, 83-88.
7. Whittemore, A.S., Harris, R., Intyre, J. and the Collaborative Ovarian Cancer Group. (1992) Characteristics relating the ovarian cancer risk: collaborative analysis of 12 US case-control studies. Am. J. Epidemiol., 136, 1184-1220.
8. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995a) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet, 346, 1575-1582.
9. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995b) Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet, 346, 1582-1588.